{"disease":{"id":"fanconi-anemia","name":"fanconi anemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT00027274","title":"Cancer in Inherited Bone Marrow Failure Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":4000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03050268","title":"Familial Investigations of Childhood Cancer Predisposition","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT07005297","title":"Clinical Genetics Branch Eligibility Screening Survey","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT00542373","title":"Widefield Fluorescence and Reflectance Imaging Systems and Oral Tissue Samples in Monitoring Participants at Risk for Developing Oral Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":338,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06490510","title":"Prognostic Significance of Mutation Type and Chromosome Fragility in Fanconi Anemia","phase":"","overall_status":"COMPLETED","enrollment_count":227,"lead_sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","has_results":false},{"nct_id":"NCT05687149","title":"Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05973656","title":"Role of Acetaldehyde in the Development of Oral Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":170,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT00352976","title":"TBI Dose De-escalation for Fanconi Anemia","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":true},{"nct_id":"NCT01316549","title":"Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT00856388","title":"Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders","phase":"NA","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT03579875","title":"Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT00053989","title":"NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT04042831","title":"Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"Academic and Community Cancer Research United","has_results":false},{"nct_id":"NCT00630253","title":"Cytoxan, Fludara, and Antithymocyte Globulin Conditioning Followed By Stem Cell Transplant in Treating Fanconi Anemia","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":true},{"nct_id":"NCT03609814","title":"Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT)","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04232085","title":"Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT03206086","title":"Eltrombopag for People With Fanconi Anemia","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":25,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT03609827","title":"Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT03609840","title":"Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT06744283","title":"Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT03398824","title":"Pilot Study of Metformin for Patients With Fanconi Anemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Boston Children's Hospital","has_results":true},{"nct_id":"NCT00258427","title":"Hematopoietic Stem Cell Transplantation in High Risk Patients With Fanconi Anemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":true},{"nct_id":"NCT03351868","title":"FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector","phase":"NA","overall_status":"UNKNOWN","enrollment_count":10,"lead_sponsor_name":"Shenzhen Geno-Immune Medical Institute","has_results":false},{"nct_id":"NCT00001399","title":"Gene Therapy for the Treatment of Fanconi's Anemia Type C","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT04437771","title":"Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Rocket Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT03157804","title":"Lentiviral-mediated Gene Therapy of Fanconi Anemia Patients Subtype A","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Hospital Infantil Universitario Niño Jesús, Madrid, Spain","has_results":false},{"nct_id":"NCT06045052","title":"Eltrombopag for Treatment of Fanconi Anemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Julian Sevilla","has_results":false},{"nct_id":"NCT04248439","title":"Gene Therapy for Fanconi Anemia, Complementation Group A","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5,"lead_sponsor_name":"Rocket Pharmaceuticals Inc.","has_results":false},{"nct_id":"NCT02678533","title":"Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and Plerixafor","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05910853","title":"Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia","phase":"","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Sanguine Biosciences","has_results":false},{"nct_id":"NCT03600909","title":"A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT01331018","title":"Gene Therapy for Fanconi Anemia","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"Fred Hutchinson Cancer Center","has_results":false},{"nct_id":"NCT05598515","title":"Time-restricted Feeding to Reduce Inflammation in Fanconi Anemia","phase":"NA","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT06958380","title":"Corrective Exercise and Rehabilitation in Fanconi Anemia: A Case Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"Pardis Specialized Wellness Institute","has_results":false},{"nct_id":"NCT04656171","title":"Microcephaly, Fanconi Anemia and Praxial Disorders","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06731036","title":"Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"University of Florida","has_results":false}],"total":37},"guidelines":[],"source":"Drug Landscape verified database"}